novel compound (cholesterol)
Evaluation of Novel Compound Benzoylphenyl Indole Carboxamide Effect on Hyperlipidemic and Hyperglycemic Rat
... a novel compound N-[4-benzoylphenyl]-1H-indole- 2-carboxamide on diet-induced hyperlipidemic (prepared by mixing cholesterol ...the novel compound showed no significant effect on glucose level ...
7
The novel compound NO 1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis
... We have discovered a novel compound, NO-1886, which possesses a powerful lipoprotein lipase (LPL) activity-increasing action. Administration of NO-1886 increased LPL activity in the postheparin plasma, ...
8
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report
... In summary, here we report a new case of TRMA syn- drome in a patient descended from non-consanguineous Chinese parents. A novel compound heterozygote mutation in the SLC19A2 gene comprising a duplication ...
6
In-Silico Modelling And Molecular Docking Studies Of A Novel Compound Isolated From
... of novel molecules with affinity to a target, the clarification of absorption, distribution, metabolism, excretion and toxicity properties as well as physicochemical ...active novel compound henicosa ...
6
Anti-oxidant Activity of Novel Compound (AVO) Derived from L-arginine
... It can be concluded from current study that the activity of novel compound derived from arginine AVO acted as a strong potential of antioxidant agent. It has the ability to minimized the hazard effects of ...
12
A novel compound heterozygous mutation of the SMARCAL1 gene leading to mild Schimke immune-osseous dysplasia: a case report
... of novel compound mutations of SMARCAL1 in two female siblings, while Simon [11] reported novel SMARCAL1bi-allelic mutations by employing whole-exome sequencing ...a novel splice site mutation ...
6
A small molecule screen identifies a novel compound that induces a homeotic transformation in Hydra
... Several features of Hydra suggested that it would be amenable to screens for small molecules that affect patterning. Hydra is kept in a simple, non-sterile culture medium, and can go without feeding for a week or more. ...
10
Lethal perinatal hypophosphatasia caused by a novel compound heterozygous mutation: a case report
... (p.A154V) was the novel mutation. Three-dimensional structure model was used to predict functional impair- ment of the mutant TNAP protein, which provided an explanation of the two mutated alleles correlating with ...
5
Novel AARS2 Gene Mutation Producing Leukodystrophy: A Patient with Peripheral Demyelinating Polyneuropathy
... [7] Song, C., Peng, L., Wang, S., et al . (2019) A Novel Compound Heterozygous Muta- tion in AARS2 Gene (c.965 G > A, p.R322H; c.334 G > C, p.G112R) Identified in a Chinese Patient with Leukodystrophy ...
5
Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report
... identified novel compound heterozygous muta- tions of the POLR3A gene that caused POLR3-related leukodystrophy in the patient combined with the clinical presentation, MRI brain pattern, and medical exome ...
6
THE BENZOYLSALICYLAMIDE AND THE 4 FLUOROBENZOYLSALICYLAMIDE, THE NOVEL SALICYLAMIDE DERIVATIVES AND THE ANALGESIC ACTIVITIES COMPARATIVE
... the novel salicylamide derivatives had been synthesized. The novel compound benzoylsalicylamide and the 4-fluorobenzoylsalicylamide were synthesized by The Schotten Baumann method, where the reaction ...
7
A novel case of compound heterozygous congenital hyperinsulinism without high insulin levels
... Case: This patient initially presented at 11 months with seizure activity secondary to severe hypoglycemia. Her diagnostic evaluation included genetic studies, which confirmed congenital hyperinsulinism. A novel ...
5
Structure and magnetic ordering in the defect compounds ErGe1 83
... the compound ErGe 2 is of particular interest as it is The broadness of the peaks in the DTA trace does not reported to undergo two polymorphic transformations at allow us to define the transformation temperatures ...
6
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD)
... Usually, patients with SMARCAL1 biallelic missense mutations or a missense and a nonsense mutation have a milder disease. Accordingly, our patient, compound het- erozygous for a novel missense mutation ...
5
Vol 69, No 2 (2017)
... isolating novel bioactive compound-producing actinomycetes from the special ecosystem of bark by a colony count of actinomycetes, determination of the total number of actinomycetes species and ...
7
A novel polyoxometalate supramolecular compound: [La(H2O)9]2[V10O28]·8H2O† †
... 3+ charge plays a guest role in the polyacid supramolecular compound. The oxidation number of La is three and the oxidation number of V is five. All the coordination polyhedrons of V are distorted octahedrons. The ...
14
<p>Antibacterial Activity of a Novel Biocomposite Chitosan/Graphite Based on Zinc-Grafted Mesoporous Silica Nanoparticles</p>
... Introduction: A novel biocomposite chitosan/graphite based on zinc-grafted mesoporous silica nanoparticles (CGZM-bio) was synthesized and the antibacterial activities of this compound al[r] ...
13
A zinc–lanthanum carboxylate complex, [LaZn2L6(NO3)(bipy)2] (L = α methylacrylate and bipy = 2,2′ bipyridine)
... A zinc±lanthanum carboxylate complex, [LaZn2L6NO3bipy2] L = a-methylacrylate and bipy = 2,20 -bipyridine The crystal structure of the title novel heteronuclear coordination compound, tri[r] ...
12
Investigation of Benzimidazole Compound as a Novel Corrosion Inhibitor for Mild Steel in Hydrochloric Acid Solution
... Weight loss experiments were carried out on mild steel sheets with wt% composition as follows: C, 0.15; Mn, 0.32; P, 0.05; balance, Fe and with the size of 2 cm × 2 cm × 0.5 cm. The mild steel specimens were abraded by ...
13
Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
... DCZ3301 is a novel aryl-guanidino compound with molecular weight of 464.0 (Figure 1A). We first evaluated the effect of DCZ3301 by in vitro proliferation assays against nine human cancer cell lines. The ...
10